Analystreport

Globus Medical Inc (NYSE: GMED) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $55.00 price target on the stock.

Globus Medical, Inc. Class A  (GMED) 
Last globus medical, inc. class a earnings: 2/20 04:15 pm Check Earnings Report
US:NYSE Investor Relations: investors.globusmedical.com